By Ron Shinkman, Editor, Laboratory Industry Report
With its second quarter earnings report, LabCorp has officially eclipsed Quest Diagnostics as the nation's largest laboratory company.
LabCorp reported net income for the second quarter ending June 30 of $168.4 million on revenue of $2.2 billion. Quest reported net income of $129 million on revenue of $1.93 billion.
LabCorp leapfrogged Quest with its recent acquisition of pharmaceutical testing firm Covance. The acquisition contributed $621 million in …
Read more...
 Seamless Interoperability Between Your Laboratory and the Practice EMR: ELLKAY Makes It Happen
To compete in today's healthcare market, laboratories are seeking long-term connectivity partners who will help them add value to their services, assist referring physicians in delivering better outcomes, and improve bottom lines. Since 2002, ELLKAY has been committed to making interoperability happen, acting as a one-stop-shop for laboratory connectivity.
For over a decade, we have been connecting laboratories to EMR/PM systems, building a strong foundation of laboratory expertise, and growing our comprehensive knowledgebase of structured data and system connectivity. Partnering with ELLKAY enables laboratories to take advantage of the relationships and connectivity we have built with hundreds of EMR systems.
Our quality support and full-service solutions have made us a nationwide leader in providing connectivity throughout the healthcare continuum. We empower diagnostic laboratories with powerful, cost-effective technologies and solutions they need to increase revenue and market-share, including
- Solutions for electronic orders and results
- Implementing and managing interfaces with EMRs
- Cross-reference mapping for insurance codes, test codes, and LOINC codes
- Real-time connectivity to patient demographic and insurance information.
With connectivity to 500+ PM/EMR systems in 31,000+ practices, we are the healthcare industry's "Data Plumbers," building the data pipeline for laboratories, hospitals, PM/EMR systems, HIEs, ACOs, and other healthcare organizations.
www.ELLKAY.com | 201-791-0606
By Stephanie Murg, Managing Director, G2 Intelligence
With the Food and Drug Administration poised to reverse its "enforcement discretion" and begin regulating laboratory-developed tests (LDTs) in the near future, industry groups are on the offensive. On August 4, the Association for Molecular Pathology (AMP; Bethesda, Md.) issued its own proposal for "modernization of CLIA regulations for laboratory-developed testing procedures (LDPs)." Representatives from AMP presented the recommendations to the Senate Health, Education, Labor, and Pensions (HELP) Committee, which is now drafting legislation that would…
Read more...
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Illumina (San Diego) selected the next round of startup companies for its genomics accelerator. This is the second, six-month cycle for the Illumina Accelerator, which seeks to aid entrepreneurs and early-stage companies working on "scientifically and commercially promising" next-generation sequencing applications by…
Read more...
By Kelly A. Briganti, Editorial Director, G2 Intelligence
Recognizing that laboratory tests "influence between 70 to 80 percent of clinical decisions," the Food and Drug Administration, Centers for Disease Control and Prevention (CDC) and the National Library of Medicine (of the National Institutes of Health) are holding a public workshop Sept. 28, 2015, to improve ease of sharing laboratory data. The agencies seek public input on "promoting semantic interoperability of laboratory data between in vitro diagnostic devices and…
Read more...
|
